Reuters logo
BRIEF-Eyegate Pharmaceuticals posts Q3 ‍net loss $4.1 mln vs $3.4 mln a year ago
2017年11月14日 / 下午1点21分 / 9 天前

BRIEF-Eyegate Pharmaceuticals posts Q3 ‍net loss $4.1 mln vs $3.4 mln a year ago

Nov 14 (Reuters) - Eyegate Pharmaceuticals Inc

* Eyegate Pharmaceuticals reports third quarter 2017 financial results and provides business update

* Eyegate Pharmaceuticals Inc - ‍net loss in Q3 of 2017 was $4.1 million, compared with $3.4 million in Q3 of 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below